PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Oct-2024 aap Implantate AG: Step-by-step restart of IT systems aap Implantate AG
18-Oct-2024 EMA Grants PRIME Status to Pentixapharm’s Lead Candidate PentixaFor Pentixapharm Holding AG
18-Oct-2024 ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies ProductLife Group (PLG)
18-Oct-2024 OncoZenge AB intends to enter partnership with Pharmanovia for commercialization of BupiZenge™ in Europe, Middle East & North Africa OncoZenge AB
18-Oct-2024 Johnson & Johnson transitions Remicade® (infliximab) and Simponi® (golimumab) for treatment of patients with Inflammatory Diseases Johnson & Johnson
18-Oct-2024 LEARN ABOUT TREATING AND MANAGING DEMENTIA AT A SPECIAL WEBINAR EVENT Luye Pharma Ltd
18-Oct-2024 Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress Biognosys
18-Oct-2024 eXmoor and Virica receive funding to improve AAV gene therapy manufacturing eXmoor pharma
18-Oct-2024 AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands Global Specialty Pharmaceutical Wholesale and Product Distribution Services AscellaHealth LLC
18-Oct-2024 Blue Mountain Announces Launch of Blue Mountain University: A Premier e-Learning Experience for RAM Software Users Blue Mountain
18-Oct-2024 Partnerships build trust between industry and healthcare professionals ABPI
17-Oct-2024 STRATEC POSTS PRELIMINARY RESULTS FOR FIRST NINE MONTHS OF 2024: TARGET CORRIDOR FOR ADJUSTED EBIT MARGIN CONFIRMED WITH ADJUSTMENT TO 2024 SALES GUIDANCE STRATEC SE
17-Oct-2024 How to Start Your Own Pharma Tablet Manufacturing Business in India: Insights from Roma Pharma Roma Pharma Private Limited
17-Oct-2024 Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 Sartorius Stedim Biotech SA
16-Oct-2024 ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at IDWeek 2024 ViiV Healthcare
16-Oct-2024 OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain OKYO Pharma Limited
16-Oct-2024 Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share Cycle Pharmaceuticals Ltd
16-Oct-2024 APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA AG
16-Oct-2024 APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA AG
16-Oct-2024 Invitation: Straumann Group 2024 third-quarter results webcast Straumann Holding AG